postoperative complicaqtions.
Conditions
Interventions
Intervention 1: Intervention group: group of receive 0.1 micgr/kg intravenously Dexmedetomidine made by Exire company, during 10 minutes immediately after induction. Intervention 2: Intervention group
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age range of 65-18 years old American Society of Anesthesiologists (ASA) score of II and III Patient agrees to participate in the study
Exclusion criteria
Exclusion criteria: Receiving drugs that affect hemodynamic status Receiving ?Anticoagulant drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Pressure. Timepoint: In every 10 minutes during surgery and recovery. Method of measurement: Pulse oximetry, Observation.;Heart Rate. Timepoint: In every 10 minutes during surgery and recovery. Method of measurement: Pulse oximetry.;Blood Oxygen Saturation. Timepoint: In every 10 minutes during surgery and recovery. Method of measurement: Pulse oximetry.;Nausea. Timepoint: During stay of patients in recovery. Method of measurement: Observation.;Vomitting. Timepoint: During stay of patients in recovery. Method of measurement: Observation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic disorder. Timepoint: Every 10 minutes during surgery and recovery. Method of measurement: pulse oximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Taghi Hashemi
Esfahan University of Medical Sciences
Outcome results
None listed